Scientist, Preclinical Research
Bold Therapeutics is a clinical-stage biopharmaceutical company focused on rapid and efficient development of novel metallotherapeutics. Earlier in 2023, Bold Therapeutics announced positive interim Phase 2 results for its lead product, BOLD-100, in the treatment of advanced colorectal, biliary tract and gastric cancers at AACR and ASCO, respectively. Bold Therapeutics expects to initiate a pivotal Phase 3 trial in advanced colorectal cancer in 2024, as well as numerous parallel Phase 2 trials. Concurrently, Bold Therapeutics is building a robust pipeline of novel metallotherapeutics. Comprising a small, dedicated team of industry experts, Bold Therapeutics aims to make a difference by rapidly advancing these novel therapeutic approaches.
Bold Therapeutics is seeking to hire a Scientist to join and expand our preclinical research team. The successful candidate will support Bold Therapeutics’ preclinical oncology research efforts, with a focus on cellular biology and understanding the mechanism of action of BOLD-100 and our other metallotherapeutics. The role involves collaborating with Bold Therapeutics’ research team, as well as our network of academic and industry partners, to advance the understanding of our key assets. The successful candidate should be enthusiastic about working in a small biotech environment and be able to thrive in an exciting, fast-paced translational environment where collaboration is key. The position will primarily focus on preclinical drug development and will involve supporting and interacting with all facets of the company, including clinical, manufacturing, corporate, and business development.
The successful candidate must possess strong scientific skills and experience in oncology, with a focus on designing and managing experiments to determine the mechanism of action of complex therapeutics. The candidate should be detail-oriented when it comes to experimental design and capable of working with contract laboratories. Additionally, the candidate must be self-motivated and have excellent interpersonal skills. Strong analytical skills and exceptional written and oral communication skills are essential. This position requires a high level of organization and initiative, along with a proven ability to work both independently and as part of a multidisciplinary team. The position reports to the Senior Director of Preclinical Development.
Specific duties and responsibilities will include:
- Designing assays and experiments to understand lead metallotherapeutic compounds
- Collaborating with current academic collaborators and CROs to advance research priorities
- Identifying new academic collaborators/CROs to advance research priorities
- Managing specific research projects and experiments
- Developing strategies to identify hit and lead metallotherapeutic compounds
- Writing internal reports and external papers on results from studies
- Becoming a subject matter expert on topics of relevance to metallotherapeutic
- Summarizing and extracting important information from study results and reporting them to the team
- Support manufacturing, regulatory, clinical, and business development priorities, as needed
REQUIRED TECHNICAL QUALIFICATIONS
- PhD in an appropriate field
- Experience in oncology is required
- Industry experience is an asset
- Research experience, including post-doctoral research, in oncology drug development, drug discovery and lead identification, stress pathways, and metal-based therapeutics is an asset
- Solid written and oral communication skills in the English required
- Legally authorized to work in Canada
DESIRED START DATE
HOW TO APPLY
If this opportunity matches your character, experience, and skill set, and you would like to work in an exciting and dynamic team developing innovative therapeutics, this position is open and we are looking for the right candidate. Please email a cover letter and your resume to the attention of Michelle Koersen at email@example.com. Applications will not be accepted over the phone.